Clinical Scorecard: AI Diagnostic Tool Shows Higher Accuracy Than Physicians in Simulated Cases
At a Glance
| Category | Detail |
|---|---|
| Condition | AI-assisted diagnostic test selection and diagnosis in simulated clinical encounters |
| Key Mechanisms | Diagnostic Orchestrator (DxO), using large language models, asks questions, requests investigations, and updates its diagnosis as evidence becomes available. |
| Target Population | 304 published clinicopathological conference cases and 325 emergency department encounters; real-world patient populations were not evaluated. |
| Care Setting | Controlled, text-based evaluation using published clinicopathological cases and emergency department encounters. |
Key Highlights
- The SDBench framework included 304 clinicopathological conference cases and 325 emergency department encounters.
- Using GPT-5, DxO achieved 83% accuracy on clinicopathological cases versus 36% for physicians with reference materials, and 80% versus 47% on emergency department cases.
- For clinicopathological cases, DxO achieved 81% accuracy at an estimated average testing cost of $2,241; physicians achieved 36% accuracy at an estimated cost of $4,725.
- DxO generally asked more questions than clinicians before ordering investigations.
- The evaluation was text-based and excluded physical examination, pathology slides, imaging data, incomplete records, and multidisciplinary decision-making.
Guideline-Based Recommendations
Diagnosis
- The study reports that DxO asks questions, requests investigations, and updates its diagnosis as evidence becomes available.
- The researchers state that the evaluation was conducted in simulated, text-based cases and did not establish performance in routine clinical practice.
Management
- The researchers describe potential use of AI to assist clinicians with diagnostic test selection and diagnostic stewardship.
- The researchers state that further evaluation is needed to establish effectiveness in real-world practice and effects on patient outcomes.
Monitoring & Follow-up
- The study assessed diagnostic accuracy and estimated investigation costs.
- Testing costs were estimates, not observed expenditure.
Risks
- DxO can request examination findings but cannot perform physical examinations or observe patients directly.
- The controlled text-based evaluation excluded pathology slides, imaging data, incomplete records, and multidisciplinary decision-making.
Patient & Prescribing Data
No patient treatment or prescribing population was evaluated; the study used simulated clinicopathological cases and emergency department encounters.
The article reports diagnostic performance and estimated testing costs, not treatment efficacy, medication use, or prescribing outcomes.
Clinical Best Practices
- The researchers note that accuracy and cost comparisons were obtained in a controlled, text-based evaluation.
- The researchers state that further evaluation is needed to establish real-world effectiveness and effects on patient outcomes.
- The article reports that DxO can request examination findings but cannot perform physical examinations or observe patients directly.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
